Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

BioLineRx (BLRX) Inventory Average (2023 - 2025)

Historic Inventory Average for BioLineRx (BLRX) over the last 3 years, with Q3 2025 value amounting to $2.5 million.

  • BioLineRx's Inventory Average fell 2991.08% to $2.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.5 million, marking a year-over-year decrease of 2991.08%. This contributed to the annual value of $2.5 million for FY2024, which is N/A changed from last year.
  • Latest data reveals that BioLineRx reported Inventory Average of $2.5 million as of Q3 2025, which was down 2991.08% from $3.1 million recorded in Q2 2025.
  • Over the past 5 years, BioLineRx's Inventory Average peaked at $3.6 million during Q3 2024, and registered a low of $1.7 million during Q4 2023.
  • Its 3-year average for Inventory Average is $2.9 million, with a median of $3.2 million in 2025.
  • Its Inventory Average has fluctuated over the past 5 years, first skyrocketed by 10239.03% in 2024, then tumbled by 2991.08% in 2025.
  • Quarter analysis of 3 years shows BioLineRx's Inventory Average stood at $1.7 million in 2023, then skyrocketed by 102.39% to $3.3 million in 2024, then fell by 24.79% to $2.5 million in 2025.
  • Its Inventory Average stands at $2.5 million for Q3 2025, versus $3.1 million for Q2 2025 and $3.2 million for Q1 2025.